Skip to content

/ Allergy Control Program

Allergy Control Program

New Job, New Allergies: Common Workplace Allergens

November 12, 2019

In a recent blog, we dove into adult onset allergies and discovered that there is no proven reason (yet!) as to why allergies suddenly appear in adulthood. Dr. Mary Morris, Allergychoices Medical Advisor, partner at Allergy Associates of La Crosse and a lead author of the La Crosse Method™ Protocol, had a few ideas as to why…

Read More

The Hidden Costs of Allergy to Employers: How to Crack the Code

July 10, 2019

When looking at the top healthcare costs impacting employers today, allergy is typically not top of mind. Cancer, diabetes, heart disease and musculoskeletal issues usually receive top billing, and are often easier to identify in employee groups. Allergy, on the other hand, is commonly hidden under related conditions and co-morbidities, making it difficult for organizations…

Read More

20 Billion Reasons to Start Treating the Cause of Allergies

June 11, 2019

And no, that’s not an exaggeration. The top 200 medications, in terms of retail sales, were recently released for 2018. While the medications on this list treat a wide variety of conditions – from diabetes to cystic fibrosis – allergy made a not-so-surprising appearance on the list. Nine of the medications on the list, totaling…

Read More

How much are you spending on your seasonal allergies?

May 15, 2019

You stayed on budget on your spring break trip. No home improvement projects. No shopping sprees.  Where did your money disappear to this spring? Environmental allergies are more than a nuisance; they’re costly. Below are five allergy-related costs you may have contributed to this spring. Over the counter (OTC) products After a few days of…

Read More

Does SLIT impact asthma? New review indicates yes.

August 8, 2018

Big news for sublingual immunotherapy came in the form of a comparative effectiveness review recently. A group of allergy researchers compared 31 subcutaneous immunotherapy studies, 18 sublingual immunotherapy studies, and 5 combined studies “to assess the efficacy and safety of immunotherapy for treating allergic asthma.” The results showed that overall, immunotherapy is a valid treatment…

Read More

The Cost of Allergy – A Business Case for Treating the Cause with SLIT

July 27, 2016

Allergic disease affects nearly 60 million Americans (20% of the population) and this number continues to grow. With the startling numbers of Americans affected by allergic disease, it should not be a shock that allergies are the leading medical related cause of productivity loss for businesses. According to the Harvard Business Review, a 2004 study…

Read More